Search results
Earnings call: Lantheus reports robust growth, eyes $1B in PYLARIFY sales By Investing.com
Investing.com· 5 days agoLantheus (NASDAQ:LNTH) Holdings, Inc. (ticker: LNTH), a leader in diagnostic and therapeutic...
Earnings call: Corcept Therapeutics raises 2024 revenue guidance
Investing.com· 6 days agoCorcept Therapeutics Incorporated (NASDAQ: CORT ) has reported a strong financial performance for...
Earnings call: PROCEPT BioRobotics sees 83% revenue surge in Q1 2024
Investing.com· 6 days agoPROCEPT BioRobotics (ticker: PRCT) reported an 83% revenue increase in the first quarter of 2024,...
TAR-200 monotherapy shows greater than 80% complete response rate in patients with high-risk...
St. Louis Post-Dispatch· 5 days agoJohnson & Johnson announced today updated results from Cohort 2 of the Phase 2b SunRISe-1 study evaluating the efficacy and safety of investigational TAR-200 monotherapy in patients with BCG-unresponsive ...